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files were assessed using the Delirium Rating Scale-Revised-98 (DRS-R98).
Results: Twenty percent patients had delirium, 19.3% had SSD, 29.8% had dementia-only, and 31%
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tia. DRS-R98 scores showed ascending severity from NDND , dementia-only , SSD , delirium.
DRS-R98 scores for items evaluating the three core symptom domains (cognitive, higher-order
thinking, and circadian) distinguished SSD from delirium and both from nondelirium groups.
DRS-R98 profiles were essentially the same in delirium and SSD subgroups with or without demen-
tia, although total scale scores were generally higher when in comorbid subgroups.
Discussion: SSD shared characteristic core domain symptoms with delirium, which distinguished
each from nondelirium groups, although severity was intermediate in the subsyndromal group.
Delirium core symptoms overshadowed the dementia phenotype when comorbid. Milder distur-
bances of delirium core domain symptoms are highly suggestive of SSD.
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Subsyndromal delirium (SSD) is thought to represent a
subthreshold state related to delirium and associated with
poor posthospitalization outcomes similar to those associ-
ated with delirium [1–8]. However, it lacks a standardized
definition, even in Diagnostic and Statistical Manual of
Mental Disorders, fifth edition (DSM-5) [9] where it is
only noted as an “attenuated delirium syndrome” without
specific criteria.
Early attempts at categorical delineation of SSD required
the presence of fewer symptoms than for syndromal
delirium, although the specific symptoms were arbitrarily
selected, did not involve severity determinations, and
required only one or two symptoms that had not been empir-
ically chosen for specificity to the delirium syndrome
[1,3,6,7,10–13].
Another approach was dimensional that defined subsyn-
dromal by lower severity score cutoffs than for delirium
diagnosis, using the Delirium Rating Scale-Revised-98
(DRS-R98) [14] or the Intensive Care Delirium Screening
Checklist [15]. Those ranges for SSD were estimates based
on known distributions of scores in studies of delirium but
not discerned from direct research [5,8,16–21].
More recent efforts to characterize SSD used an empirical
approach to delineate a subsyndromal group. Cluster anal-
ysis of DRS-R98 items (n 5 859) confirmed an SSD group
with intermediate severity between delirium and no-
delirium that had a similar pattern of core domain symptoms
(cognitive, circadian, and higher-order thinking) previously
demonstrated to reflect the characteristic delirium phenotype
as the delirium group [22]. To enable clinician diagnosis
they proposed criteria where an acute change from baseline
accompanied by mild disturbances of sleep-wake cycle,
thought process, orientation, attention, and visuospatial abil-
ity together would define SSD and distinguish it from nonde-
lirium and delirium.
More recently, Meagher et al. [23] compared two
approaches to define SSD in 311 subjects, either by a
DRS-R98 total scale score range of 7 to 11 points or by
the presence of any two of four features on the Confusion
Assessment Method [24]. The Confusion Assessment
Method diagnosed more SSD cases than the DRS-R98
(13.2% vs. 7.7%) but with only modest case concordance
(50% of DRS-R98 defined cases) between approaches.
They proposed SSD clinical criteria as follows: (1) absence
of full syndromal delirium, (2) acute or subacute onset, (3)
disturbed attention, and (4) evidence of other cognitive
and/or neuropsychiatric disturbances not better accounted
for by another neuropsychiatric condition.
Better understanding of SSD can inform future revisions
of DSM-5 and International Classification of Diseases-10 to
increase its clinical recognition. Furthermore, Meagher and
Trzepacz [25] have emphasized the need for research to
improve phenomenological distinctions between delirium
and SSD with dementias. Therefore, the aim of this studywas to further examine phenomenology of SSD as defined
by the proposed Meagher et al. [23] criteria and to under-
stand the particular features that distinguished it from
DSM-5 delirium, dementia with or without comorbid
delirium, and subjects with neither delirium nor dementia.
We analyzed data from two settings of elderly inpatients
that were similarly obtained by our extended delirium
research teams.2. Methods
2.1. Subjects
Subjects derived from two prospective cross-sectional
studies that used similar methods of assessment for delirium
status and phenomenology obtained by our extended
delirium research teams are as follows: (1) a sample of
200 consecutive elderly acute general medical admissions
to a university teaching hospital in Sligo (Ireland) [26],
and (2) a group of 200 consecutive patients admitted to a
skilled nursing home (NH) in Reus (Spain) [27].
All patients aged 70 years and older newly admitted to the
general hospital (GH) were asked to participate in the study
within the first 72 hours after admission. All patients
admitted to the NH were assessed during the first 24 to
48 hours. In both samples, patients were excluded if they
(1) had been studied on a previous admission, or (2) had se-
vere communicative problems or did not speak the respec-
tive native language (English or Spanish). Of 439 eligible
patients, 39 were excluded (see Supplemental Fig. 1). In
each setting, patients were recruited consecutively until
200 subjects were included, allowing for a final sample of
400 subjects.
In the GH sample, assessments were conducted by two
raters trained in administering the scales with high inter-
rater reliability established before the study. Each participant
was interviewed by the same rater with the full battery of
scales. Patients from the NH sample were evaluated inde-
pendently by two experienced raters after running a pilot
test with 10 patients (not included in the study sample) to
evaluate logistic difficulties and possible problems in using
research instruments. The first rater evaluated patients to
rate DSM-5 criteria, whereas the second (specifically trained
in DRS-R98 administration) administered the Spanish DRS-
R98. A third researcher contacted the family or a caregiver to
administer the Spanish–Informant Questionnaire on Cogni-
tive Decline in the Elderly (IQCODE) to determine the de-
mentia status.
Demographic (including gender and age) and clinical
data were collected from files and medical records.2.2. Diagnosis
2.2.1. Delirium
Patients who met DSM-5 criteria for delirium by the clin-
ical research staff were classified as having delirium. We
E. Sepulveda et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 7 (2017) 1-10 3evaluated each patient for delirium using DSM-5 criteria ac-
cording to all available information from clinical assessment
of the patient, discussion with nursing staff, and available
collateral sources. In the GH sample, to assess “awareness”
for the A criterion, researchers used the relevant item from
the Reversible Cognitive Dysfunction Scale [28,29]. The
item has a four-point range, but we assigned a dichotomous
(normal/abnormal) score by collapsing the three categories
of abnormality into one. In the NH sample, researchers de-
signed a diagnostic criteria checklist to dichotomously rate
each item as present or not according to the subjective
impression of the assessing clinician, where awareness
was based on the patient engaging appropriately with the
interviewer and their environment.
2.2.2. Subsyndromal delirium
We applied the Meagher et al. [23] criteria to the nonde-
lirium cases to delineate the SSD group. Criteria were (1)
absence of full syndromal delirium, (2) acute or subacute
onset, (3) disturbed attention, and (4) evidence of other
cognitive and/or neuropsychiatric disturbances not better ac-
counted for by another neuropsychiatric condition. To
demonstrate the presence of symptoms for criteria (2)
through (4) in a standardized fashion we required a nonzero
score on the respective relevant DRS-R98 item. Otherwise,
DRS-R98 item or scale score ranges were not used as deter-
minants of SSD.
2.2.3. Dementia
All patients were assessed for dementia. Those having de-
mentia could be comorbid with delirium, SSD, or dementia-
only.
In the Irish sample, dementia was defined using DSM-5
criteria (major neurocognitive disorder) according to all
available sources (medical files, GP files, collateral history,
and evidence from neuroimaging reports).
In the Spanish sample, the Spanish-IQCODE was used to
diagnose dementia. This is a structured interview comprising
26 questions posed to an informant about the patient’s cogni-
tion and function during the preceding 5 years. Scores range
from 26 to 130. The validated Spanish version uses a cutoff
.85 for possible dementia [30].
2.2.4. No-delirium/no-dementia
Patients who were not classified by the previously
described definitions for delirium, SSD, or dementia were
classified as the no-delirium/no-dementia (NDND) group.2.3. Delirium Rating Scale-Revised-98
The DRS-R98 [14] is a widely used, well-validated tool
used to evaluate delirium phenomenological severity and
profile. This scale includes descriptive anchors for 13
severity (rated from 0 to 3) and three diagnostic items (rated
0 to 2 or 3) where 0 means normal. The DRS-R98 severity
scale maximum score is 39 points and DRS-R98 total scalescore is 46, with higher scores indicating more severe
delirium. Items can be subgrouped to represent symptoms
of the three core domains of delirium as follows: cognitive
(items 9–13), circadian (items 1, 7, and 8), and higher-
order thinking (items 5 and 6). The scale has high validity
and inter-rater reliability values in all its versions, including
the original English [14] and Spanish translation [31,32].
2.4. Ethical approval
The study was approved by the institutional review board
and the research ethics committees at each center. The pro-
cedures and rationale for the study were explained to all pa-
tients and relatives but because many patients had cognitive
impairment at study entry, it was presumed that some might
not be capable of giving informed written consent. Because
of the noninvasive nature of the study, ethics committee
approval was given to augment patient assent with proxy
consent from next of kin (where possible) or a responsible
caregiver for all participants, in accordance with the
Helsinki Guidelines for Medical Research involving human
subjects [33].
2.5. Statistical analysis
Datawere analyzed using Statistical Package for the Social
Sciences (SPSS, v 21, IBM, Armonk, NY). Continuous vari-
ables were expressed as the means 6 standard deviation and
discrete variables as frequencies and percentages (%). Chi-
square test was used to compare gender, presence of demen-
tia, and frequencies of the four study groups between GH and
NH facilities, and t test was used for the comparison of age.
To evaluate internal consistency of DRS-R98 in this com-
bined sample, Cronbach’s a was performed for its total and
severity scale items in the whole sample and in both GH and
NH samples.
For comparison of the DRS-R98 diverse scores among
groups, we used Mann-Whitney U test (pairwise compari-
sons) and Kruskal-Wallis analysis of variance with post
hoc pairwise comparisons with Mann-Whitney U test. We
used chi-square to compare the frequency of occurrence of
scores 1 or 2 for individual DRS-R98 items.
The P value was set at,.05, except when multiple signif-
icance tests were carried out when Bonferroni correction
was applied as specified in the corresponding tables.3. Results
3.1. Sample description
The demographic and general clinical characteristics in
the pooled sample and samples by setting are shown in
Table 1. The mean age for the whole sample was
79.7 6 8.5 years, 50.8% were women and 60.8% had pre-
existing dementia. The groups differed only for mean age
(81.1 6 6.5 for GH sample and 78.3 6 9.9 for NH sample,
P 5 .001) but not for gender or occurrence of dementia.
Table 1
Clinical and demographic characteristics of the sample of 400 patients from
a skilled NH and a university GH
Variable
Whole sample
(n 5 400)
NH
(n 5 200)
GH
(n 5 200)
Age* 79.7 6 8.5 78.3 6 9.9 81.1 6 6.5
Gender: male 197 (49.3) 97 (48.5) 100 (50.0)
Previous dementia 243 (60.8) 117 (58.5) 126 (63.0)
DRS-R98 severity
scale Cronbach’s a
0.861 0.891 0.832
DRS-R98 total scale
Cronbach’s a
0.892 0.917 0.861
Abbreviations: DRS-R98, Delirium Rating Scale-Revised-98; GH, gen-
eral hospital; NH, nursing home.
NOTE. Values are expressed as the mean 6 standard deviation for age,
number (%) for gender and previous cognitive impairment, and Cronbach’s
a coefficient for internal consistency of DRS-R98 scores between the
cohorts.
*NH , GH (P 5 .001).
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excellent in the pooled data set and individual GH and NH
settings.
Classification of the pooled sample into diagnostic
groups found 80 patients (20.0%) with delirium, 77
(19.3%) with SSD, 119 (29.8%) with dementia-only, and
124 (31%) with NDND. Delirium frequency was signifi-
cantly higher in the NH group (27% vs. 13%) (P , .001),
whereas the GH group had a higher frequency ofTable 2
DRS-R98 scores for 400 elderly subjects by diagnostic group: delirium, SSD, dem
DRS-R98 NDND (n 5 124)
1. Sleep-wake cycle disturbance*yzxk 0.53 6 0.62
2. Perceptions and hallucinations*yx 0.07 6 0.41
3. Delusions*y 0.09 6 0.44
4. Lability of affect*yzx{ 0.04 6 0.20
5. Language*yzxk{ 0.06 6 0.33
6. Thought process abnormalities*yzxk 0.10 6 0.30
7. Motor agitation*yzx 0.05 6 0.22
8. Motor retardation*yzxk 0.12 6 0.35
9. Orientation*yzxk{ 0.17 6 0.45
10. Attention*yzxk 0.15 6 0.38
11. Short-term memory*y{ 0.43 6 0.78
12. Long-term memory*yzx{ 1.01 6 1.02
13. Visuospatial ability*yzxk{ 0.31 6 1.08
14. Temporal onset of symptoms*yzx{ 0.06 6 0.26
15. Fluctuation of symptom severity*yzxk 0.00 6 0.00
16. Physical disorder*yzx 0.27 6 0.62
DRS-R98 severity*yzxk{ 3.11 6 2.64
DRS-R98 total*yzxk{ 3.44 6 2.90
Abbreviations: DRS-R98, Delirium Rating Scale-Revised-98; NDND, no-delir
NOTE. Scores are expressed as the means6 standard deviation and compared
comparisons with Mann-Whitney U test). Footnotes describe details of score comp
according to the Bonferroni correction.
*NDND , SSD.
yNDND , delirium.
zDementia , delirium.
xDementia , SSD.
kSSD , delirium.
{NDND , dementia.dementia-only cases (35% vs. 24.5%, P 5 .02). There
were no differences in frequency of SSD or NDND between
the two settings.
DRS-R98 severity and total scale scores significantly
distinguished all four groups, with a pattern of ascending
burden of delirium severity by the diagnostic group:
NDND , dementia-only , SSD , delirium (Table 2).
3.2. Comparison of DRS-R98 mean item scores by group
Table 2 shows DRS-R98 mean item scores according to
diagnostic groups in the pooled sample and after correction
for multiple comparisons. These results revealed delirium
groups to be largely distinguishable from the two nondeli-
rium groups especially for core domain symptoms, and
that the SSD group had intermediate severity of core domain
symptoms between the delirium and two nondelirium
groups. Noncore items did not have a useful pattern for
group discrimination.
Specifically, all core domain items’ mean scores distin-
guished SSD and delirium groups with the exception of mo-
tor agitation and memory items. Noncore symptoms (items
2, 3, and 4) did neither discriminate between them nor did
temporal onset or physical attribution items.
All core domain symptoms except short-term memory
were significantly worse in both delirium groups as
compared with the dementia-only group. Specifically,
these were orientation, attention, long-term memory;entia-only, and NDND
Dementia (n 5 119) SSD (n 5 77) Delirium (n 5 80)
0.67 6 0.75 1.17 6 0.77 1.50 6 0.76
0.24 6 0.76 0.64 6 1.11 0.41 6 0.87
0.24 6 0.76 0.42 6 0.85 0.28 6 0.71
0.18 6 0.43 0.40 6 0.61 0.53 6 0.66
0.18 6 0.49 0.68 6 0.82 1.20 6 1.07
0.19 6 0.47 0.71 6 0.76 1.28 6 1.04
0.11 6 0.34 0.61 6 0.73 0.81 6 0.90
0.13 6 0.34 0.73 6 0.81 1.16 6 0.96
0.69 6 0.84 1.27 6 0.81 2.04 6 0.82
0.26 6 0.50 1.42 6 0.57 1.89 6 0.78
1.06 6 1.14 1.30 6 1.19 1.50 6 1.19
1.60 6 1.09 2.21 6 0.99 2.49 6 0.86
0.71 6 0.86 1.42 6 0.85 1.96 6 0.91
0.22 6 0.52 1.49 6 0.66 1.65 6 0.81
0.03 6 0.18 0.44 6 0.57 0.75 6 0.63
0.43 6 0.78 1.14 6 0.88 1.45 6 0.74
6.26 6 3.68 12.96 6 5.41 17.10 6 6.35
6.94 6 4.13 16.01 6 6.18 20.89 6 7.25
ium/no-dementia; SSD, subsyndromal delirium.
between groups with Kruskal-Wallis analysis of variance (post hoc pairwise
arisons. All P values for multiple pairwise comparisons were set at,.0083
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cess abnormalities (higher-order thinking); and sleep-wake
cycle, motor agitation, and motor retardation (circadian)
items.
Regarding noncore symptoms, the dementia-only group
had less severe lability of affect than both delirium groups
and less severe perceptual disturbances than the SSD
group.
As expected, greater mean severity for every symptom
distinguished both delirium groups from NDND. The latter
group also had lower scores than the dementia-only group
on language and all cognitive items except attention.3.3. Comparison of delirium phenomenology by clinical
setting
DRS-R98 mean item scores were largely comparable be-
tween clinical settings for each group (Table 3). Most
notably, short-term memory was more impaired in the GH
sample for all groups.3.4. Impact of dementia on DRS-R98 profiles for SSD and
delirium
Table 4 compares DRS-R98 mean scores for SSD and
delirium subgroups with and without comorbid dementia,
where 63 of 77 subjects with SSD (82%) and 61 of 80
with delirium (76%) had comorbid dementia. Overall
delirium severities on DRS-R98 total and severity scales
were higher when dementia was comorbid with deliriumTable 3
DRS-R98 scores for the 400 subjects according to the clinical setting for each of
DRS-R98
NDND (n 5 124) Dementia-only (
NH (n 5 63) GH (n 5 61) NH (n 5 49) G
1. Sleep-wake cycle disturbance 0.43 6 0.53 0.64 6 0.68 0.37 6 0.49 0
2. Perceptions and hallucinations 0.13 6 0.55 0.02 6 0.13 0.33 6 0.90 0
3. Delusions 0.17 6 0.61 0* 0.51 6 1.04 0
4. Lability of affect 0.06 6 0.25 0.02 6 0.13 0.27 6 0.53 0
5. Language 0.10 6 0.43 0.03 6 0.18 0.33 6 0.66 0
6. Thought process abnormalities 0.19 6 0.40 0* 0.39 6 0.64 0
7. Motor agitation 0.03 6 0.18 0.07 6 0.25 0.08 6 0.34 0
8. Motor retardation 0.11 6 0.32 0.13 6 0.39 0.16 6 0.37 0
9. Orientation 0.25 6 0.57 0.08 6 0.28 1.10 6 0.85 0
10. Attention 0.19 6 0.43 0.10 6 0.30 0.31 6 0.55 0
11. Short-term memory 0.06 6 0.30 0.80 6 0.93* 0.37 6 0.83 1
12. Long-term memory 0.89 6 1.03 1.13 6 0.99 1.78 6 0.98 1
13. Visuospatial ability 0.11 6 0.32 0.51 6 1.48* 0.57 6 0.91 0
14. Temporal onset of symptoms 0.03 6 0.18 0.08 6 0.33 0.18 6 0.39 0
15. Fluctuation of symptoms 0 0 0 0
16. Physical disorder 0.13 6 0.38 0.43 6 0.76* 0.22 6 0.47 0
DRS-R98 severity scale 2.73 6 2.52 3.52 6 2.72 6.55 6 3.72 6
DRS-R98 total scale 2.89 6 2.71 4.03 6 3.00* 6.96 6 3.82 6
Abbreviations: DRS-R98, Delirium Rating Scale-Revised-98; GH, general hosp
mal delirium.
NOTE. Values are expressed as the means 6 standard deviation; P values betw
Whitney U test with P values at ,.05.
*Values with significant difference between the two sites.or SSD except for the total scale on the delirium group com-
parison.
However, DRS-R98 item profiles for core domain symp-
toms were largely the same in both SSD and delirium groups
irrespective of subgroup dementia status, with only a few
differences. Memory was more impaired in the comorbid
delirium subgroup, but temporal onset was less acute. Also
delusions and fluctuation of symptoms were worse in the
SSD comorbid subgroup.
3.5. Comparison of dementia patients according to
delirium status
Somewhat conversely, Table 5 compares the phenomeno-
logical profile of subjects with dementia (n 5 243) accord-
ing to their delirium syndromal status (dementia-only,
dementia with SSD, and dementia with delirium). Nearly
all items were significantly lower for dementia-only than
for comorbid dementia with either SSD or delirium. There
was a significant gradient of increasing scores across groups
from dementia-only to dementia with SSD to dementia with
delirium on DRS-R98 severity and total scales.
Most DRS-R98 items had a similar ascending pattern
when comparing dementia-only to the delirium/dementia
comorbid groups, although not significantly for all items.
SSD with dementia was significantly worse than dementia-
only on all items except for short-term memory. Delirium
with dementia was significantly higher than dementia-only
on all items except for delusions.
Delirium with dementia was significantly higher than
SSD with dementia on language, thought process,the four diagnostic groups: NDND, dementia-only, SSD, and delirium
n 5 119) SSD (n 5 77) Delirium (n 5 80)
H (n 5 70) NH (n 5 34) GH (n 5 43) NH (n 5 54) GH (n 5 26)
.89 6 0.83* 0.97 6 0.67 1.33 6 0.81 1.61 6 0.71 1.27 6 0.83
.17 6 0.64 0.71 6 1.12 0.58 6 1.12 0.50 6 0.93 0.23 6 0.71
.06 6 0.38* 0.71 6 1.03 0.19 6 0.59* 0.35 6 0.83 0.12 6 0.33
.13 6 0.34 0.59 6 0.66 0.26 6 0.54* 0.56 6 0.69 0.46 6 0.58
.09 6 0.28* 0.79 6 0.91 0.58 6 0.73 1.41 6 1.02 0.77 6 1.07*
.06 6 0.23* 1.06 6 0.73 0.44 6 0.67* 1.43 6 1.02 0.96 6 1.04
.13 6 0.34 0.68 6 0.81 0.56 6 0.67 0.89 6 0.90 0.65 6 0.89
.11 6 0.32 0.76 6 0.89 0.70 6 0.74 1.39 6 0.98 0.69 6 0.74*
.40 6 0.71* 1.50 6 0.83 1.09 6 0.75* 2.07 6 0.84 1.96 6 0.77
.23 6 0.46 1.29 6 0.52 1.51 6 0.59 1.91 6 0.85 1.85 6 0.61
.54 6 1.07* 0.62 6 1.04 1.84 6 1.02* 1.04 6 1.10 2.46 6 0.71*
.47 6 1.15 2.24 6 1.05 2.19 6 0.96 2.33 6 0.97 2.81 6 0.40*
.81 6 0.82* 1.24 6 0.99 1.56 6 0.70 2.06 6 1.00 1.77 6 0.65
.24 6 0.60 1.41 6 0.56 1.56 6 0.73 1.76 6 0.80 1.42 6 0.81
.06 6 0.23 0.62 6 0.60 0.30 6 0.51* 0.94 6 0.56 0.35 6 0.56*
.57 6 0.91 1.38 6 0.70 0.95 6 0.97 1.61 6 0.56 1.12 6 0.95*
.09 6 3.68 13.21 6 6.15 12.81 6 4.90 17.63 6 7.05 16.00 6 4.48
.96 6 4.36 16.56 6 6.62 15.63 6 5.92 21.85 6 7.82 18.88 6 5.51
ital; NDND, no-delirium/no-dementia; NH, nursing home; SSD, subsyndro-
een sites within each group. Pairwise comparisons are made by the Mann-
Table 4
Comparison of DRS-R98 scores for elderly patients with SSD and delirium between subgroups with or without comorbid dementia
DRS-R98
SSD without dementia
(n 5 14)
SSD with dementia
(n 5 63)
Delirium without dementia
(n 5 19)
Delirium with dementia
(n 5 61)
1. Sleep-wake cycle disturbance 0.93 6 0.92 1.22 6 0.73 1.47 6 0.77 1.51 6 0.77
2. Perceptions and hallucinations 0.43 6 0.94 0.68 6 1.15 0.16 6 0.37 0.49 6 0.96
3. Delusions 0.00 6 0.00 0.51 6 0.91* 0.11 6 0.46 0.33 6 0.77
4. Lability of affect 0.21 6 0.43 0.44 6 0.64 0.42 6 0.61 0.56 6 0.67
5. Language 0.50 6 0.65 0.71 6 0.85 1.16 6 0.90 1.21 6 1.13
6. Thought process abnormalities 0.43 6 0.65 0.78 6 0.77 1.11 6 0.88 1.33 6 1.09
7. Motor agitation 0.36 6 0.50 0.67 6 0.76 0.58 6 0.96 0.89 6 0.88
8. Motor retardation 0.57 6 0.85 0.76 6 0.80 1.16 6 0.96 1.16 6 0.97
9. Orientation 1.00 6 0.68 1.33 6 0.82 1.74 6 0.93 2.13 6 0.76
10. Attention 1.43 6 0.65 1.41 6 0.56 1.63 6 0.90 1.97 6 0.73
11. Short-term memory 0.93 6 1.07 1.38 6 1.21 0.79 6 1.03 1.72 6 1.16*
12. Long-term memory 1.86 6 1.23 2.29 6 0.92 1.95 6 0.97 2.66 6 0.75*
13. Visuospatial ability 1.43 6 0.85 1.41 6 0.85 1.68 6 0.75 2.05 6 0.94
14. Temporal onset of symptoms 1.43 6 0.65 1.51 6 0.67 2.00 6 0.82 1.54 6 0.79*
15. Fluctuation of symptom severity 0.14 6 0.36 0.51 6 0.59* 0.79 6 0.71 0.74 6 0.60
16. Physical disorder 1.00 6 0.96 1.17 6 0.87 1.63 6 0.68 1.39 6 0.76
DRS-R98 severity scale 10.07 6 3.91 13.63 6 5.56* 14.05 6 5.94 18.05 6 6.22*
DRS-R98 total scale 12.64 6 4.20 16.79 6 6.37* 18.37 6 7.11 21.67 6 7.17
Abbreviations: DRS-R98, Delirium Rating Scale-Revised-98; SSD, subsyndromal delirium.
NOTE. Values are expressed as the means6 standard deviation. Pairwise comparisons between subgroups according to dementia status made using Mann-
Whitney U test with P values at ,.05.
*Values with significant difference.
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ability but not on any circadian symptoms.
3.6. Comparison of DRS-R98 item score frequencies by
group
Categorical comparisons for item frequencies for the
presence of symptoms at any severity level (DRS-R98 scores
1) are shown in bar graphs (Fig. 1A). The two delirium
groups were distinguished from the two nondelirium groups
by nearly every item except that psychotic items (2 and 3)
and memory items (11 and 12) generally did not. All items
differentiated SSD from NDND.
Using this cutoff score that included mild, moderate, and
severe levels of symptoms lumped together was not useful to
distinguish SSD from delirium, where only fluctuation of
symptoms distinguished them. However, when using a cut-
off of 2 (Fig. 1B), delirium was more distinguishable
from SSD on many items (sleep-wake cycle, language,
thought process, orientation, and attention) representing
each of the three core domains.
Noncore domain items were not useful to distinguish
among the four groups. However, the presence of an attribut-
able physical disorder and acute onset of symptoms was
differentiating and reflective of delirium status.
Using the higher threshold, a significantly greater pres-
ence of all items representing core domains, except short-
term memory, distinguished dementia-only from both
delirium groups. Only orientation and short-term memory
did not distinguish dementia-only from SSD. Moreover, fre-
quencies for all core domain items were significantly higher
in delirium and SSD compared with NDND.4. Discussion
Given the challenges of detecting SSD when comorbid
dementia may be present, we described delirium phenome-
nological profiles of elderly patients from GH and NH set-
tings. To define the SSD group, we applied the recently
proposed Meagher et al. [23] clinical criteria. We found
that SSD differed from both dementia-only and NDND
groups on severity and frequency of most DRS-R98 items
and from delirium for lesser severity of symptoms represent-
ing all three core domains. This supports it being a condition
distinguishable from both dementia and full syndromal
delirium, despite overlapping symptoms. Our finding that
SSD is subthreshold to, but characterized by, the same
unique core domain symptoms as delirium is consistent
with that previously reported by Trzepacz et al. [22] using
a cluster analysis non–a priori approach to define symptoms
of SSD . However, this is the first report of it being distin-
guishable from dementia, as noted in two different clinical
settings where delirium is common in older persons.
In addition, despite some differences in criteria, we also
found support for the more explicit SSD criteria proposed
by Trzepacz et al. [22]. The Meagher et al. criteria do not
specify the number or type of other neuropsychiatric symp-
toms besides inattention and do not restrict severities to be-
ing mild. In contrast, four symptoms (i.e., sleep-wake cycle,
thought process, attention, and visuospatial ability) reflect-
ing three core domains are required to be present at mild
severity by the Trzepacz et al. criteria. When we reviewed
our results, these four symptoms were present in the majority
of our SSD group diagnosed using theMeagher et al. criteria.
We found that many core domain items distinguished SSD
Table 5
DRS-R98 scores for the 243 patients with dementia according to diagnostic
groups: full syndromal delirium (delirium), SSD, and dementia-only
DRS-R98
Dementia
without
delirium
(n 5 119)
Dementia
with SSD
(n 5 63)
Dementia
with
delirium
(n 5 61)
1. Sleep-wake cycle
disturbance*y
0.67 6 0.75 1.22 6 0.73 1.51 6 0.77
2. Perceptions and
hallucinations*y
0.24 6 0.76 0.68 6 1.15 0.49 6 0.96
3. Delusions* 0.24 6 0.76 0.51 6 0.91 0.33 6 0.77
4. Lability of affect*y 0.18 6 0.43 0.44 6 0.64 0.56 6 0.67
5. Language*yz 0.18 6 0.49 0.71 6 0.85 1.21 6 1.13
6. Thought process
abnormalities*yz
0.19 6 0.47 0.78 6 0.77 1.33 6 1.09
7. Motor agitation*y 0.11 6 0.34 0.67 6 0.76 0.89 6 0.88
8. Motor retardation*y 0.13 6 0.34 0.76 6 0.80 1.16 6 0.97
9. Orientation*yz 0.69 6 0.84 1.33 6 0.82 2.13 6 0.76
10. Attention*yz 0.26 6 0.49 1.41 6 0.56 1.97 6 0.73
11. Short-term memoryy 1.06 6 1.14 1.38 6 1.21 1.72 6 1.16
12. Long-term memory*yz 1.60 6 1.09 2.29 6 0.92 2.66 6 0.75
13. Visuospatial ability*yz 0.71 6 0.86 1.41 6 0.85 2.05 6 0.94
14. Temporal onset of
symptoms*y
0.22 6 0.52 1.51 6 0.67 1.54 6 0.79
15. Fluctuation of symptom
severity*y
0.03 6 0.18 0.51 6 0.59 0.74 6 0.60
16. Physical disorder*y 0.43 6 0.78 1.17 6 0.87 1.39 6 0.76
Severity scale*yz 6.28 6 3.69 13.63 6 5.56 18.05 6 6.22
Total scale*yz 6.96 6 4.13 16.79 6 6.37 21.67 6 7.17
Abbreviations: DRS-R98, Delirium Rating Scale-Revised-98; SSD, sub-
syndromal delirium.
NOTE. Values expressed as the means 6 standard deviation. Compari-
sons made by Kruskal-Wallis analysis of variance, with Mann-Whitney U
post hoc pairwise analysis. Significance at P, .0166 according to the Bon-
ferroni correction.
*Dementia-only , SSD.
yDementia-only , delirium.
zSSD , delirium.
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ically, frequencies of scores 1 for items representing Trze-
pacz et al. criteria in the SSD group ranged from 81.8% for
sleep-wake cycle disturbance to 100% for attention, with the
exception that mild thought process abnormalities were pre-
sent in only 54.5%. A higher proportion of delirium than
SSD cases were rated as at least moderately affected (2
points) on symptoms from all three core domains. Therefore,
our data support that both criteria could signal to a clinician
that an acute change in mental status with mild impairment
of core domain symptoms suggests SSD.
The phenomenological profile of DSM-5 delirium and
SSD was essentially the same between the two clinical pop-
ulations, with only minor differences, probably more reflec-
tive of underlying characteristics of the different populations
than delirium per se. Most notably short-term memory
impairment was worse in the GH for both delirium groups.
This study reports the first comparison of SSD occurrence
between two settings using DSM-5 criteria, where previous
work suggested that the inclusiveness of diagnostic systems
can vary according to the setting where they are applied[34,35]. We found similar incidence of delirium spectrum
disorders with some differences in proportion of
subsyndromal versus delirium. Delirium occurrence in
postacute care services ranges from 6% to 33.3%
[4,36–38], with higher rates identified in populations with
more severe dementia and physical comorbidity [38]. The
particular NH in our study has complex patients with a
high prevalence of severe cognitive disorders and medical-
surgical problems, which may account for the high fre-
quency of delirium (27%) versus our GH (13%). The occur-
rence of SSD was similar (17% vs. 21.5%), highlighting
consistency across clinical settings, at sufficient frequency
to deserve better detection.
The severity of delirium symptoms in the SSD group was
intermediate between delirium and the nondelirium groups
(NDND and dementia-only), which differed mainly in terms
of the severity of the three core domain symptoms [39,40] as
previously reported in studies that have defined SSD in
different ways in this work. Trzepacz et al. [22] applied bi-
nary logistic regression to find that DRS-R98 item scores
for five core domain symptoms (disturbances on sleep-
wake cycle, thought process, orientation, attention, and vi-
suospatial ability) when taken together at mild severity
(item score of 1 point) correctly classified 80% of SSD
versus no delirium.
Our study affirmed previous studies that delirium over-
shadows symptoms of dementia when they are comorbid
[41–45]. Furthermore, we found that the three core
domains are specifically affected in delirium subjects, with
or without comorbid dementia, in a way that makes them
different from nondelirious patients, including those with
only dementia [45]. Although our sample of nondemented
SSD patients was relatively small, our findings confirm
that delirium symptoms overshadow dementia symptoms
when they are comorbid. However, noncore symptoms
should not be relied on to differentiate SSD from dementia,
and among core domain symptoms, memory is less reliable
than other core symptoms.
We also found that the five items proposed by Trzepacz
et al. [22] criteria distinguished SSD comorbid with de-
mentia from dementia alone and moreover, four of these
(thought process, attention, orientation, and visuospatial
ability) also differentiated SSD from delirium, which sug-
gests focusing on those four symptoms may be useful
when detecting SSD, even among those with dementia.
The gradient of increasing scores across dementia-only
to the delirium/dementia comorbid groups highlights the
cumulative neuropsychiatric burden attributable to
delirium.
Our study had a number of limitations. First, evaluations
were conducted in two different countries by different re-
searchers and using different language versions of the
DRS-R98. However, the DRS-R98 has high inter-rater reli-
ability established in all its validation studies, researchers
at both settings were highly expert in delirium assessment,
and experienced and specifically trained in the use of the
Fig.1. Frequency of symptoms present at any severity (i.e., DRS-R98 scores 1 (A)) and at least moderate severity (DRS-R98 scores 2 (B)) for 400 elderly
subjects by diagnostic group: delirium, subsyndromal delirium (SSD), dementia-only, and no-delirium/no-dementia (NDND). Pairwise comparisons between
groups with chi-square, P values at,.0083 according to the Bonferroni correction. Color-coded squares above bars indicate other groups for which the labeled
group was statistically different on that DRS-R98 item. Abbreviation: DRS-R98, Delirium Rating Scale-Revised-98.
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items was excellent and similar across these two samples.
Also, the DSM-5 criteria were only recently published and
discrepancies may exist in the way some criteria are inter-
preted by different raters [26,46,47]. The approach to
establish unawareness and the presence of previous
cognitive impairment or dementia differed at the two sites
(i.e., clinical criteria vs. Spanish-IQCODE for dementia),
which could explain some of the differences in the popula-
tions’ characteristics.Our cross-sectional design could not differentiate whether
SSD represents a stable condition or an evolving or resolving
delirium, which warrants future longitudinal studies. Finally,
we did not consider the possible impact of other neuropsychi-
atric conditions (e.g., depression) that are common in elderly
patients. However, uniquely, we addressed the impact of de-
mentia on SSD phenomenology.
In summary, when using the Meagher et al. [23] proposed
SSD criteria, we largely supported prior literature that SSD’s
symptoms are subthreshold to that of delirium but
E. Sepulveda et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 7 (2017) 1-10 9distinguishable from dementia-only or nondemented-
nondelirious groups, especially when focusing on the three
core domain symptoms. Our work contributes more symp-
tom specificity to the understanding of SSD than previous
work using total scale score ranges and lends hope that it
can be detected even in elderly who carry a high risk for co-
morbid dementia.
In conclusion, we found that both delirium and SSD are
common in elderly patients receiving care in acute GH and
NH settings where dementia was commonly comorbid,
and both populations had discernible SSD that is worthy of
being detected and distinguished from dementia.
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1. Systematic review: The authors reviewed the litera-
ture using traditional (e.g., PubMed) sources and
meeting abstracts and presentations. Subsyndromal
delirium (SSD) has been defined in different ways
but there are no standardized criteria for it, notwith-
standing its clinical relevance and the known diffi-
culties to distinguish it from delirium and dementia.
2. Interpretation: SSD is very prevalent in two elderly
populations and has symptoms with intermediate
severity between full syndromal delirium and no
delirium, including in patients with dementia,
centered on the core symptom domains. Also,
delirium overshadows dementia symptoms.
3. Future directions: Our work provides a deeper under-
standing of the phenomenology of SSD and serves a
basis for future research on specific criteria requiring
the three core delirium symptom domains in its defi-
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